No Pharma Money
News & Reports
News January 21, 2020

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

 
1. LOL

  • This week, pharma CEOs convened to pitch ideas on how to lower drug prices. Not one offered lower prices as a solution. ? — (CNBC) 

2. Triple for Taxpayers

  • Multiple sclerosis drugs tripled in cost to Medicare and Medicaid in the last seven years. So far, 2020 is more of the same. — (Science Daily) 

3. Out of Touch

  • Insulin maker Eli Lilly is touting new, lower-priced insulin. Too bad $265 isn’t a deal. — (Reuters)

4. Why are Drug Prices So High?

  • One big cause: patent abuse. How do we fix that? I-MAK’s Priti Krishtel explains. — (TEDWomen)

5.  Zolgensma Dystopia

  • Parents should not have to play the lottery for the health of their children. We need to put an end to Big Pharma’s predatory tactics. — (CTVNews)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.